3.2900
-0.0600
(-1.79%)
At close: January 10 at 4:00:02 PM EST
3.3708
+0.08
+(2.46%)
After hours: January 10 at 7:58:28 PM EST
Research Analysis
Earnings Estimate
| Currency in CAD | Current Qtr. (Dec 2024) | Next Qtr. (Mar 2025) | Current Year (2024) | Next Year (2025) |
|---|---|---|---|---|
| No. of Analysts | 4 | 3 | 4 | 4 |
| Avg. Estimate | -0.12 | -0.12 | -0.54 | -0.49 |
| Low Estimate | -0.12 | -0.14 | -0.56 | -0.58 |
| High Estimate | -0.1 | -0.1 | -0.53 | -0.42 |
| Year Ago EPS | -0.16 | -0.14 | -0.6 | -0.54 |
Revenue Estimate
| Currency in CAD | Current Qtr. (Dec 2024) | Next Qtr. (Mar 2025) | Current Year (2024) | Next Year (2025) |
|---|---|---|---|---|
| No. of Analysts | 5 | 4 | 5 | 5 |
| Avg. Estimate | 2.21M | 1.97M | 8.63M | 7.25M |
| Low Estimate | 1.81M | 1.81M | 8.21M | 5.2M |
| High Estimate | 2.95M | 2.24M | 9.41M | 8.24M |
| Year Ago Sales | 2.91M | 2.11M | 24.63M | 8.63M |
| Sales Growth (year/est) | -24.07% | -6.51% | -64.96% | -16.03% |
Earnings History
| Currency in CAD | 12/31/2023 | 3/31/2024 | 6/30/2024 | 9/30/2024 |
|---|---|---|---|---|
| EPS Est. | -0.16 | -0.15 | -0.13 | -0.13 |
| EPS Actual | -0.16 | -0.14 | -0.15 | -0.14 |
| Difference | -0 | 0.02 | -0.02 | -0.01 |
| Surprise % | -1.83% | 10.46% | -16.93% | -6.91% |
EPS Trend
| Currency in CAD | Current Qtr. (Dec 2024) | Next Qtr. (Mar 2025) | Current Year (2024) | Next Year (2025) |
|---|---|---|---|---|
| Current Estimate | -0.12 | -0.12 | -0.54 | -0.49 |
| 7 Days Ago | -0.11 | -0.12 | -0.54 | -0.49 |
| 30 Days Ago | -0.12 | -0.12 | -0.53 | -0.48 |
| 60 Days Ago | -0.12 | -0.12 | -0.53 | -0.48 |
| 90 Days Ago | -0.12 | -0.12 | -0.53 | -0.51 |
EPS Revisions
| Currency in CAD | Current Qtr. (Dec 2024) | Next Qtr. (Mar 2025) | Current Year (2024) | Next Year (2025) |
|---|---|---|---|---|
| Up Last 7 Days | -- | -- | -- | -- |
| Up Last 30 Days | 2 | 1 | 1 | 3 |
| Down Last 7 Days | 2 | 1 | 2 | 2 |
| Down Last 30 Days | 1 | 1 | 3 | 1 |
Growth Estimates
| Current Qtr. | Next Qtr. | Current Year | Next Year | |
|---|---|---|---|---|
| ABUS | 29.41% | 15.70% | 9.18% | 9.59% |
| S&P 500 | 8.66% | 11.51% | 14.05% | 13.39% |
Upgrades & Downgrades
| Maintains | Chardan Capital: Buy to Buy | 11/20/2024 |
| Reiterates | HC Wainwright & Co.: Buy to Buy | 11/18/2024 |
| Reiterates | HC Wainwright & Co.: Buy to Buy | 11/7/2024 |
| Maintains | Chardan Capital: Buy to Buy | 11/7/2024 |
| Maintains | Jefferies: Buy to Buy | 9/5/2024 |
| Maintains | JMP Securities: Market Outperform to Market Outperform | 8/2/2024 |
Related Tickers
ROIV Roivant Sciences Ltd.
10.63
-3.54%
ARWR Arrowhead Pharmaceuticals, Inc.
18.49
-6.38%
RIGL Rigel Pharmaceuticals, Inc.
16.25
0.00%
BCRX BioCryst Pharmaceuticals, Inc.
7.67
-4.72%
ALNY Alnylam Pharmaceuticals, Inc.
237.98
-1.07%
BLUE bluebird bio, Inc.
8.46
0.00%
ARDX Ardelyx, Inc.
5.07
-5.06%
PRQR ProQR Therapeutics N.V.
2.4200
-7.63%
VXRT Vaxart, Inc.
0.7898
-2.42%
ADAP Adaptimmune Therapeutics plc
0.6200
+0.02%